• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessment of drug-related problems and their impact on blood pressure control in patients with hypertension.高血压患者药物相关问题及其对血压控制影响的评估。
Eur J Hosp Pharm. 2016 May;23(3):126-130. doi: 10.1136/ejhpharm-2015-000712. Epub 2015 Oct 16.
2
The impact of drug related problems on health-related quality of life among hypertensive patients in Jordan.药物相关问题对约旦高血压患者健康相关生活质量的影响。
Pharm Pract (Granada). 2017 Jul-Sep;15(3):995. doi: 10.18549/PharmPract.2017.03.995. Epub 2017 Aug 23.
3
Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan.约旦门诊慢性病患者样本中的药物相关问题:一项横断面研究
Ther Clin Risk Manag. 2016 Feb 17;12:233-9. doi: 10.2147/TCRM.S98165. eCollection 2016.
4
Evaluation of the Prevalence and Risk Factors of Drug-Related Problems in Hypertension and Type 2 Diabetes Mellitus Patients at a Tertiary Care Hospital: A Cross-Sectional Study.三级护理医院高血压和2型糖尿病患者药物相关问题的患病率及危险因素评估:一项横断面研究
Cureus. 2023 Jul 31;15(7):e42775. doi: 10.7759/cureus.42775. eCollection 2023 Jul.
5
Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study.高血压 2 型糖尿病患者的药物相关问题:一项横断面回顾性研究。
BMC Endocr Disord. 2013 Jan 7;13:2. doi: 10.1186/1472-6823-13-2.
6
Prediction of drug-related problems in diabetic outpatients in a number of hospitals, using a modeling approach.采用建模方法对多家医院糖尿病门诊患者的药物相关问题进行预测。
Drug Healthc Patient Saf. 2017 Jul 28;9:65-70. doi: 10.2147/DHPS.S125114. eCollection 2017.
7
Assessment of drug-related problems in pediatric ward of Zewditu Memorial Referral Hospital, Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴泽韦迪图纪念转诊医院儿科病房药物相关问题评估。
Int J Clin Pharm. 2017 Oct;39(5):1039-1046. doi: 10.1007/s11096-017-0504-9. Epub 2017 Jul 8.
8
Evaluation of drug-related problems in older polypharmacy primary care patients.老年多病共存初级保健患者药物相关问题的评估
J Eval Clin Pract. 2017 Aug;23(4):860-865. doi: 10.1111/jep.12737. Epub 2017 Mar 29.
9
Drug-related Problems in Hypertensive Patients: A Cross-sectional Study from Indonesia.高血压患者的药物相关问题:一项来自印度尼西亚的横断面研究。
J Res Pharm Pract. 2020 Oct 8;9(3):140-145. doi: 10.4103/jrpp.JRPP_20_16. eCollection 2020 Jul-Sep.
10
Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia.药剂师主导的干预措施解决慢性髓性白血病患者药物相关问题的可接受性。
J Oncol Pharm Pract. 2021 Oct;27(7):1644-1656. doi: 10.1177/1078155220964539. Epub 2020 Oct 12.

引用本文的文献

1
Antihypertensive drug-related problems in Vietnamese ambulatory care.越南门诊护理中与抗高血压药物相关的问题。
Sci Rep. 2025 Jan 27;15(1):3378. doi: 10.1038/s41598-025-88041-0.
2
Safety and effectiveness of an herbal decoction (modified Saengmaeksan) in hypertensive patients: Protocol for a real-world prospective observational study.一种草药煎剂(改良生脉散)在高血压患者中的安全性和有效性:一项真实世界前瞻性观察研究方案
PLoS One. 2025 Jan 17;20(1):e0316276. doi: 10.1371/journal.pone.0316276. eCollection 2025.
3
The Impact of a Medication Therapy Management Service on the Outcomes of Hypertension Treatment Follow-Up Care in an Ethiopian Tertiary Hospital: A Pre-Post Interventional Study.药物治疗管理服务对埃塞俄比亚一家三级医院高血压治疗随访护理结果的影响:一项前后干预性研究。
Clin Med Insights Cardiol. 2024 Sep 18;18:11795468241274720. doi: 10.1177/11795468241274720. eCollection 2024.
4
Drug Related Problems among Older Inpatients at a Tertiary Care Setting.三级护理机构中老年住院患者的药物相关问题
J Clin Med. 2024 Mar 13;13(6):1638. doi: 10.3390/jcm13061638.
5
Drug-Related Problems and Pharmacists' Interventions in Hypertensive Outpatients: A Multicenter Prospective Study in 3 Vietnamese Hospitals.高血压门诊患者的药物相关问题及药剂师的干预措施:越南3家医院的多中心前瞻性研究
J Pharm Technol. 2023 Dec;39(6):259-268. doi: 10.1177/87551225231199358. Epub 2023 Oct 5.
6
Effect of Pharmaceutical Intervention in Pharmacologically Treated Hypertensive Patients-A Cluster-Randomized Clinical Trial: AFPRES-CLM Study.药物干预对接受药物治疗的高血压患者的影响——一项整群随机临床试验:AFPRES-CLM研究
J Pers Med. 2023 Oct 11;13(10):1484. doi: 10.3390/jpm13101484.
7
Evaluation of pharmaceutical care services in the Middle East Countries: a review of studies of 2013-2020.评价中东国家的药学服务:2013-2020 年研究综述。
BMC Public Health. 2023 Jul 17;23(1):1364. doi: 10.1186/s12889-023-16199-1.
8
The impact of telepharmacy on hypertension management in the United Arab Emirates.远程药学对阿拉伯联合酋长国高血压管理的影响。
Pharm Pract (Granada). 2022 Oct-Dec;20(4):2734. doi: 10.18549/PharmPract.2022.4.2734. Epub 2022 Oct 12.
9
Perspectives of the community in the developing countries toward telemedicine and pharmaceutical care during the COVID-19 pandemic.发展中国家社区在新冠疫情期间对远程医疗和药学服务的看法。
Pharm Pract (Granada). 2022 Jan-Mar;20(1):2618. doi: 10.18549/PharmPract.2022.1.2618. Epub 2022 Mar 4.
10
Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions.临床实践中的药物相关问题:一项横断面研究其患病率、风险因素及相关药物干预措施。
Sci Rep. 2021 Jan 13;11(1):883. doi: 10.1038/s41598-020-80560-2.

本文引用的文献

1
Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study.高血压 2 型糖尿病患者的药物相关问题:一项横断面回顾性研究。
BMC Endocr Disord. 2013 Jan 7;13:2. doi: 10.1186/1472-6823-13-2.
2
Global cardiovascular risk associated with hypertension and extent of treatment and control according to risk group.全球心血管风险与高血压相关,以及根据风险组的治疗和控制程度。
Am J Hypertens. 2012 May;25(5):561-7. doi: 10.1038/ajh.2012.2. Epub 2012 Feb 9.
3
Hypertension prevalence, awareness, treatment and control, and associated factors: results from a national survey, jordan.高血压患病率、知晓率、治疗率、控制率及相关因素:约旦全国性调查结果
Int J Hypertens. 2011;2011:828797. doi: 10.4061/2011/828797. Epub 2011 Dec 1.
4
The case for evidence-based pharmaceutical care.循证药学服务的理由。
Res Social Adm Pharm. 2015 May-Jun;11(3):e146-7. doi: 10.1016/j.sapharm.2009.06.001. Epub 2009 Jul 29.
5
Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitus.老年合并糖尿病患者的高血压药物治疗选择:复方药物治疗与联合药物治疗。
Drugs Aging. 2010 Nov 1;27(11):871-83. doi: 10.2165/11538650-000000000-00000.
6
Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.药物治疗干预对连锁药店实践中血压控制的影响。
Ann Pharmacother. 2010 Jan;44(1):88-96. doi: 10.1345/aph.1L289. Epub 2009 Dec 29.
7
Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries.非西方国家临床实践中管理高血压时治疗惰性的原因。
J Hum Hypertens. 2009 Mar;23(3):151-9. doi: 10.1038/jhh.2008.117. Epub 2008 Sep 11.
8
[Factors affecting the control of blood pressure and lipid levels in patients with cardiovascular disease: the PREseAP Study].[影响心血管疾病患者血压和血脂水平控制的因素:PREseAP研究]
Rev Esp Cardiol. 2008 Mar;61(3):317-21.
9
Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension.药学服务对顽固性高血压患者血压控制及健康相关生活质量的影响。
Am J Health Syst Pharm. 2007 Sep 15;64(18):1955-61. doi: 10.2146/ajhp060547.
10
Validation of a comprehensive classification tool for treatment-related problems.一种用于治疗相关问题的综合分类工具的验证
Pharm World Sci. 2006 Aug;28(4):222-32. doi: 10.1007/s11096-006-9048-0. Epub 2006 Oct 26.

高血压患者药物相关问题及其对血压控制影响的评估。

Assessment of drug-related problems and their impact on blood pressure control in patients with hypertension.

作者信息

Abu Farha Rana, Basheti Iman, Abu Al Ruz Hassan, Alsaleh Akram, AbuRuz Salah

机构信息

Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, University of Jordan, Amman, Jordan.

Department of Clinical Pharmacy, Faculty of Pharmacy, Applied Science University, Amman, Jordan.

出版信息

Eur J Hosp Pharm. 2016 May;23(3):126-130. doi: 10.1136/ejhpharm-2015-000712. Epub 2015 Oct 16.

DOI:10.1136/ejhpharm-2015-000712
PMID:31156832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6451509/
Abstract

OBJECTIVES

Hypertension is among the leading causes of cardiovascular disease worldwide. No previous studies have examined specifically the types of drug-related problems (DRPs) in patients with hypertension, and how these problems affect blood pressure control. So, the primary aim of this study was to investigate the prevalence and nature of DRPs in outpatients with hypertension and reveal any associations between DRPs and blood pressure control in these patients.

METHODS

This was a cross-sectional correlation study. A total of 200 patients who fulfilled the inclusion criteria were recruited through outpatient clinics. Patients' data were assessed to identify DRPs using a systematic evidence-based approach.

RESULTS

Two hundred participants were recruited in this cross-sectional study. About half of the participants (48.5%) had uncontrolled hypertension. The average number of DRPs was 6.31±2.63. The main identified DRPs affecting blood pressure control included patients' lack of knowledge about their medications, lack of adherence to their medications, suboptimal efficacy of medications prescribed and the need for additional monitoring. Logistic regression analysis was performed to identify the most important predictors, and significant associations were found between poor blood pressure control and the above-identified variables except for knowledge about medication (p≤0.05).

CONCLUSION

The number of DRPs among patients with hypertension is relatively high. These DRPs were associated with poor blood pressure control. The implementation of clinical pharmacy services for all patients with hypertension is strongly recommended.

摘要

目的

高血压是全球心血管疾病的主要病因之一。此前尚无研究专门探讨高血压患者的药物相关问题(DRP)类型,以及这些问题如何影响血压控制。因此,本研究的主要目的是调查高血压门诊患者中DRP的患病率和性质,并揭示这些患者中DRP与血压控制之间的任何关联。

方法

这是一项横断面相关性研究。通过门诊招募了总共200名符合纳入标准的患者。采用基于系统证据的方法评估患者数据以识别DRP。

结果

本横断面研究招募了200名参与者。约一半的参与者(48.5%)患有未控制的高血压。DRP的平均数量为6.31±2.63。确定的影响血压控制的主要DRP包括患者对其药物缺乏了解、未坚持服药、所开药物疗效欠佳以及需要额外监测。进行逻辑回归分析以确定最重要的预测因素,发现除了对药物的了解外,血压控制不佳与上述变量之间存在显著关联(p≤0.05)。

结论

高血压患者中的DRP数量相对较高。这些DRP与血压控制不佳有关。强烈建议为所有高血压患者实施临床药学服务。